Pages that link to "Q39516141"
Jump to navigation
Jump to search
The following pages link to Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities (Q39516141):
Displaying 50 items.
- Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing (Q21131890) (← links)
- A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges (Q21132483) (← links)
- Current Management Strategies in Breast Cancer by Targeting Key Altered Molecular Players (Q26765877) (← links)
- The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy (Q26768290) (← links)
- Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis (Q26776018) (← links)
- Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness (Q26827815) (← links)
- Molecular Technologies in the Clinical Diagnostic Laboratory (Q26996463) (← links)
- Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma (Q27026544) (← links)
- Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma (Q27852856) (← links)
- Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine (Q27853005) (← links)
- Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion. (Q27853146) (← links)
- Novel therapeutic strategies for patients with triple-negative breast cancer (Q28067436) (← links)
- Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials (Q28540955) (← links)
- Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer (Q30275521) (← links)
- A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest (Q30410836) (← links)
- Wnt signaling in triple negative breast cancer is associated with metastasis (Q30597238) (← links)
- Bayesian methods for expression-based integration of various types of genomics data. (Q30668548) (← links)
- Review of current methods, applications, and data management for the bioinformatics analysis of whole exome sequencing (Q30857788) (← links)
- Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer (Q30956005) (← links)
- Data Interoperability of Whole Exome Sequencing (WES) Based Mutational Burden Estimates from Different Laboratories (Q31089220) (← links)
- Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies (Q33591876) (← links)
- Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types (Q33673752) (← links)
- Integrated analysis of recurrent properties of cancer genes to identify novel drivers (Q33742981) (← links)
- Pathway-based analysis of breast cancer (Q33758011) (← links)
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease (Q33769821) (← links)
- Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes (Q33913936) (← links)
- α-catenin. A tumor suppressor beyond adherens junctions (Q34028517) (← links)
- Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function. (Q34285190) (← links)
- Translating RNA sequencing into clinical diagnostics: opportunities and challenges. (Q34519034) (← links)
- Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences (Q34654793) (← links)
- Pharmacological profiling of kinase dependency in cell lines across triple-negative breast cancer subtypes (Q34978420) (← links)
- Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44 , low in CD24 , and have loss of PTEN. (Q35027892) (← links)
- Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer (Q35190834) (← links)
- Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues. (Q35593154) (← links)
- Molecular heterogeneity in adjacent cells in triple-negative breast cancer (Q35965925) (← links)
- Evaluation and integration of cancer gene classifiers: identification and ranking of plausible drivers (Q36294122) (← links)
- Discovery and functional characterization of a neomorphic PTEN mutation. (Q36300265) (← links)
- Capture-based next-generation sequencing reveals multiple actionable mutations in cancer patients failed in traditional testing (Q36902969) (← links)
- Development and clinical application of an integrative genomic approach to personalized cancer therapy (Q36954557) (← links)
- Novel insights into breast cancer genetic variance through RNA sequencing (Q37043550) (← links)
- In vitro-differentiated neural cell cultures progress towards donor-identical brain tissue (Q37078864) (← links)
- FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells (Q37086095) (← links)
- A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer (Q37146398) (← links)
- STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer (Q37268971) (← links)
- Lipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner (Q37515517) (← links)
- Integrated genomic and epigenomic analysis of breast cancer brain metastasis (Q37529191) (← links)
- Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets. (Q37605645) (← links)
- Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway. (Q37645090) (← links)
- Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer (Q37709371) (← links)
- Triple-negative breast cancer: investigating potential molecular therapeutic target (Q38259322) (← links)